Key result
Two human iPSC lines carrying a heterozygous MYBPC3 mutation were successfully generated from an HCM patient and his daughter, demonstrating normal karyotype and pluripotency.
Why the study?
Hypertrophic cardiomyopathy is an inherited heart disease often caused by sarcomeric gene mutations, predominantly in MYBPC3, requiring cellular models to study its molecular basis and screen drugs.
Population
An HCM patient with a familial history of HCM and his daughter carrying a pathogenic non-coding mutation
Design
In vitro stem cell line generation study
Authors
Loading...
iPSC lines enable in vitro HCM modeling and screening; leaves open clinical translation pending functional validation.
The generation of these MYBPC3 mutation-carrying iPSC lines provides a valuable in vitro model for studying the molecular mechanisms of hypertrophic cardiomyopathy and for drug screening.
Liu et al. (2021) studied Hypertrophic cardiomyopathy (n=2). Generation of induced pluripotent stem cell (iPSC) lines was evaluated on Cell line morphology, pluripotency marker expression, karyotype, and in vitro differentiation capacity. Two human iPSC lines carrying a heterozygous MYBPC3 mutation were successfully generated from an HCM patient and his daughter, demonstrating normal karyotype and pluripotency.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: